Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Famotidine on Atazanavir PK
NCT00384904Phase 4Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2006
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, open-label trial of atazanavir in human immunodeficiency virus infection (HIV) (2 cohorts), sponsored by Bristol Myers Squibb. Primary endpoint: Atazanavir plasma drug concentrations at Day 25. Started Dec 2006; status: completed.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00384904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00384904.